Hikma Pharmaceuticals PLC (HIK.L) stock: key figures, P/E, revenue and dividend
Health Care · United Kingdom · ISIN GB00B0LCW083
Hikma Pharmaceuticals PLC financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 3.16 bn USD | 3.35 bn USD |
| Gross profit | 1.45 bn USD | 1.44 bn USD |
| Operating income | – | 579.92 m USD |
| EBIT | 629.00 m USD | – |
| Net income | 359.00 m USD | 410.43 m USD |
| Diluted EPS – continuing operations | 1.61 USD | 1.81 USD |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.
More stocks
- Golar LNG Ltd (GLNG)
- Zhejiang Shuanghuan Driveline Co Ltd (002472.SZ)
- Shanghai 2345 Network Holding Group (002195.SZ)
- Amentum Holdings, Inc. (AMTM)
- Hanwha (000880.KS)
- Eastern Bankshares, Inc. (EBC)
- Option Care Health, Inc. (OPCH)
- Holmen AB (HOLM B.ST)
- Hirose Electric Co Ltd (6806.T)
- BILL Holdings, Inc. (BILL)
- AAK AB (publ) (AAK.ST)
- Shenzhen Sunlord Electronics Co Ltd (002138.SZ)
Not investment advice. All data without warranty, price as of 21.10.2026. Details in the risk notice.